Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

October 01, 1993; Volume 44,Issue 4
  • You have access
    Structure and properties of omega-agatoxin IVB, a new antagonist of P-type calcium channels.
    M E Adams, I M Mintz, M D Reily, V Thanabal and B P Bean
    Molecular Pharmacology October 1993, 44 (4) 681-688;
  • You have access
    Calcium entry via L-type calcium channels acts as a negative regulator of adenylyl cyclase activity and cyclic AMP levels in cardiac myocytes.
    H J Yu, H Ma and R D Green
    Molecular Pharmacology October 1993, 44 (4) 689-693;
  • You have access
    Human immunodeficiency virus type 1 drug-resistance patterns with different 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives.
    J Balzarini, A Karlsson and E De Clercq
    Molecular Pharmacology October 1993, 44 (4) 694-701;
  • You have access
    Anti-human immunodeficiency virus type 1 therapy and peripheral neuropathy: prevention of 2',3'-dideoxycytidine toxicity in PC12 cells, a neuronal model, by uridine and pyruvate.
    S A Keilbaugh, G A Hobbs and M V Simpson
    Molecular Pharmacology October 1993, 44 (4) 702-706;
  • You have access
    Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture.
    Z Abdel-Razzak, P Loyer, A Fautrel, J C Gautier, L Corcos, B Turlin, P Beaune and A Guillouzo
    Molecular Pharmacology October 1993, 44 (4) 707-715;
  • You have access
    Drosophila nervous system muscarinic acetylcholine receptor: transient functional expression and localization by immunocytochemistry.
    A D Blake, N M Anthony, H H Chen, J B Harrison, N M Nathanson and D B Sattelle
    Molecular Pharmacology October 1993, 44 (4) 716-724;
  • You have access
    5-hydroxytryptamine1C receptor density and mRNA levels in choroid plexus epithelial cells after treatment with mianserin and (-)-1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane.
    E L Barker and E Sanders-Bush
    Molecular Pharmacology October 1993, 44 (4) 725-730;
  • You have access
    Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins.
    D E Selley, C S Breivogel and S R Childers
    Molecular Pharmacology October 1993, 44 (4) 731-741;
  • You have access
    Biochemical and immunochemical comparison of saxiphilin and transferrin, two structurally related plasma proteins from Rana catesbeiana.
    Y Li, L Llewellyn and E Moczydlowski
    Molecular Pharmacology October 1993, 44 (4) 742-748;
  • You have access
    Beta-[3H]funaltrexamine-labeled mu-opioid receptors: species variations in molecular mass and glycosylation by complex-type, N-linked oligosaccharides.
    L Y Liu-Chen, C Chen and C A Phillips
    Molecular Pharmacology October 1993, 44 (4) 749-756;
  • You have access
    Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin.
    R Bai, Z A Cichacz, C L Herald, G R Pettit and E Hamel
    Molecular Pharmacology October 1993, 44 (4) 757-766;
  • You have access
    Dual topoisomerase I and II inhibition by intoplicine (RP-60475), a new antitumor agent in early clinical trials.
    B Poddevin, J F Riou, F Lavelle and Y Pommier
    Molecular Pharmacology October 1993, 44 (4) 767-774;
  • You have access
    The phenobarbital-induced transcriptional activation of cytochrome P-450 genes is blocked by the glucocorticoid-progesterone antagonist RU486.
    P M Shaw, M Adesnik, M C Weiss and L Corcos
    Molecular Pharmacology October 1993, 44 (4) 775-783;
  • You have access
    Coupling of expressed alpha 1B- and alpha 1D-adrenergic receptor to multiple signaling pathways is both G protein and cell type specific.
    D M Perez, M B DeYoung and R M Graham
    Molecular Pharmacology October 1993, 44 (4) 784-795;
  • You have access
    Antisera against peptides derived from a purified mu-opioid binding protein recognize the protein as well as mu-opioid receptors in brain regions and a cell line.
    T L Gioannini, Y H Yao, J M Hiller, L P Taylor and E J Simon
    Molecular Pharmacology October 1993, 44 (4) 796-801;
  • You have access
    Selective coupling of alpha 2-adrenergic receptor subtypes to cyclic AMP-dependent reporter gene expression in transiently transfected JEG-3 cells.
    D J Pepperl and J W Regan
    Molecular Pharmacology October 1993, 44 (4) 802-809;
  • You have access
    Inositol-1,3,4,5-tetrakisphosphate induces calcium mobilization via the inositol-1,4,5-trisphosphate receptor in SH-SY5Y neuroblastoma cells.
    R A Wilcox, R A Challiss, C Liu, B V Potter and S R Nahorski
    Molecular Pharmacology October 1993, 44 (4) 810-817;
  • You have access
    Indirect inhibition by bradykinin of cyclic AMP generation in isolated rat glomeruli and mesangial cells.
    J L Bascands, C Pecher and J P Girolami
    Molecular Pharmacology October 1993, 44 (4) 818-826;
  • You have access
    BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.
    S R Childers, L M Fleming, D E Selley, R W McNutt and K J Chang
    Molecular Pharmacology October 1993, 44 (4) 827-834;
  • You have access
    A selective adenosine antagonist (8-cyclopentyl-1,3-dipropylxanthine) eliminates both neuromuscular depression and the action of exogenous adenosine by an effect on A1 receptors.
    R S Redman and E M Silinsky
    Molecular Pharmacology October 1993, 44 (4) 835-840;
  • You have access
    Discovery of a novel class of neuromedin B receptor antagonists, substituted somatostatin analogues.
    M Orbuch, J E Taylor, D H Coy, J E Mrozinski, S A Mantey, J F Battey, J P Moreau and R T Jensen
    Molecular Pharmacology October 1993, 44 (4) 841-850;
  • You have access
    Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors.
    K Williams
    Molecular Pharmacology October 1993, 44 (4) 851-859;
  • You have access
    U-93631 causes rapid decay of gamma-aminobutyric acid-induced chloride currents in recombinant rat gamma-aminobutyric acid type A receptors.
    G H Dillon, H K Im, B J Hamilton, D B Carter, R B Gammill, T M Judge and W B Im
    Molecular Pharmacology October 1993, 44 (4) 860-865;
  • You have access
    Potentiation of gamma-aminobutyric acid-induced chloride currents by various benzodiazepine site agonists with the alpha 1 gamma 2, beta 2 gamma 2 and alpha 1 beta 2 gamma 2 subtypes of cloned gamma-aminobutyric acid type A receptors.
    H K Im, W B Im, B J Hamilton, D B Carter and P F Vonvoigtlander
    Molecular Pharmacology October 1993, 44 (4) 866-870;
  • You have access
    Ethanol inhibits a neuronal ATP-gated ion channel.
    C Li, L Aguayo, R W Peoples and F F Weight
    Molecular Pharmacology October 1993, 44 (4) 871-875;
  • You have access
    Zinc selectively inhibits flux through benzodiazepine-insensitive gamma-aminobutyric acid chloride channels in cortical and cerebellar microsacs.
    M F Davies, P A Maguire and G H Loew
    Molecular Pharmacology October 1993, 44 (4) 876-881;
  • You have access
    Role of threonine 342 in helix 7 of the 5-hydroxytryptamine type 1D receptor in ligand binding: an indirect mechanism for receptor selectivity.
    A Smolyar and R Osman
    Molecular Pharmacology October 1993, 44 (4) 882-885;
  • You have access
    New activation model for the histamine H2 receptor, explaining the activity of the different classes of histamine H2 receptor agonists.
    J C Eriks, H van der Goot and H Timmerman
    Molecular Pharmacology October 1993, 44 (4) 886-894;
  • You have access
    Selective and synergistic inhibition of human immunodeficiency virus type 1 reverse transcriptase by a non-nucleoside inhibitor, MKC-442.
    S Yuasa, Y Sadakata, H Takashima, K Sekiya, N Inouye, M Ubasawa and M Baba
    Molecular Pharmacology October 1993, 44 (4) 895-900;
  • You have access
    Chemical properties of carbonic anhydrase IV, the membrane-bound enzyme.
    T H Maren, G C Wynns and P J Wistrand
    Molecular Pharmacology October 1993, 44 (4) 901-905;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 44, Issue 4
1 Oct 1993
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics